Dr Lalchandani Labs Ltd.
| BSE: 541299 |
Sector: Health care |
| NSE: N.A. |
ISIN Code: INE871Z01013 |
|
BSE
00:00 | 24 Jun
|
25.10
|
1.60
(6.81%)
|
OPEN
25.10
|
HIGH
25.10
|
LOW
25.10
|
|
NSE
05:30 | 01 Jan
|
Dr Lalchandani Labs Ltd
|
| OPEN |
25.10 |
| PREVIOUS CLOSE |
23.50 |
| VOLUME |
4000 |
| 52-Week high |
52.50 |
| 52-Week low |
18.05 |
| P/E |
11.67 |
| Mkt Cap.(Rs cr) |
11 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
0.00 |
| Sell Qty |
0.00 |
| OPEN |
|
| PREVIOUS CLOSE |
|
| VOLUME |
|
| 52-Week high |
0.00 |
| 52-Week low |
0.00 |
| P/E |
11.67 |
| Mkt Cap.(Rs cr) |
11 |
| Buy Price |
|
| Buy Qty |
|
| Sell Price |
|
| Sell Qty |
|
| OPEN |
25.10 |
| CLOSE |
23.50 |
| VOLUME |
4000 |
| 52-Week high |
52.50 |
| 52-Week low |
18.05 |
| P/E |
11.67 |
| Mkt Cap.(Rs cr) |
11 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
0.00 |
| Sell Qty |
0.00 |
| OPEN |
|
| PREVIOUS CLOSE |
|
| VOLUME |
|
| 52-Week high |
0.00 |
| 52-Week low |
0.00 |
| P/E |
11.67 |
| Mkt Cap.(Rs cr) |
10.87 |
| Buy Price |
|
| Buy Qty |
|
| Sell Price |
|
| Sell Qty |
|
Dr Lalchandani Labs Ltd. (DRLALCHANDLAB) - Chairman Speech
Company chairman speech
Dear Shareholders It is my pleasure to welcome you all to the 04th Annual General Meeting of DrLalchandani Labs Limited for the year 2020-2021. Dr Lalchandani Labs Limited is an NABL accredited lab functional in the area ofpathology radiology hospital lab management doctor consultation corporate healthcheck-ups since inception of our pathology lab as a proprietorship firm in the year 1986and we have been trying to cater our clients with excellent pathology and diagnosticservices. In order to achieve the said goal we arrange various training programs for ourstaff members to equip them with the latest technologies and amendments to cope up withthe changing needs of the market. We expect Dr Lalchandani Labs Limited to be one of the top listed laboratories offeringpathology and diagnostic services in next 5 years with various labs and diagnostic centersat different regions of the country. The company has strong belief to fulfill its commitment and make all dedicated as wellas sincere efforts in executing its planning and strategies. Accordingly the companyspreading its wings in almost each and every corner of India by developing requisiteinfrastructure in order to provide desired/ satisfactory services to our valued customers. The continued growth of the company in this situation of COVID -19 we are always beenproactive in supporting various Government Initiatives and helping communities around usand had successfully obtain the approval from Indian Council of Medical Research [ICMR]for COVID -19 RT-PCR testing. The growth of the company could not be well accelerated without the help of our lendinginstitutes who have supported in our liquidity requirements at the continuous interval weare generous to have their confidence in our vision and future prospects. At the end I would also like to place on record my sincere thanks to all ourwell-wishers associates vendors customers employees and members of the Board who havecontributed to the success of your Company. Lastly I would also like to thank all thestakeholders for their loyalty and continuous support in helping us achieve our vision ofbringing quality health care to our society and also look forward to a positiveinteraction with all in the days to come. Sd/- Dr Arjan Lalchandani Chairman & Managing Director Dr Lalchandani Labs Limited.
|
Quick Links for Dr Lalchandani Labs:
